$2.45T
Total marketcap
$89.24B
Total volume
BTC 50.45%     ETH 15.25%
Dominance

Allergy Therapeutics plc AGY.L Stock

2.85 GBP {{ price }} 0.000000% {{change_pct}}%
Exchange
LSE
Market Cap
135.84M GBP
LOW - HIGH [24H]
0.0000 - 0.0000 GBP
VOLUME [24H]
2.24M GBP
{{ volume }}
P/E Ratio
0
Earnings per share
-0.06 GBP

Allergy Therapeutics plc Price Chart

Allergy Therapeutics plc AGY.L Financial and Trading Overview

Allergy Therapeutics plc stock price 2.85 GBP
Previous Close 5 GBP
Open 0 GBP
Bid 0 GBP x 0
Ask 0 GBP x 0
Day's Range 0 - 0 GBP
52 Week Range 0 - 21.5 GBP
Volume 0 GBP
Avg. Volume 0 GBP
Market Cap 42.44M GBP
Beta (5Y Monthly) 0.950191
PE Ratio (TTM) N/A
EPS (TTM) -0.06 GBP
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 35 GBP

AGY.L Valuation Measures

Enterprise Value 30.27M GBP
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) -31.2
Price/Sales (ttm) 0.58327925
Price/Book (mrq) 104.16667
Enterprise Value/Revenue 0.416
Enterprise Value/EBITDA -3.688

Trading Information

Allergy Therapeutics plc Stock Price History

Beta (5Y Monthly) 0.950191
52-Week Change -99.70%
S&P500 52-Week Change 20.43%
52 Week High 21.5 GBP
52 Week Low 0 GBP
50-Day Moving Average 0.06 GBP
200-Day Moving Average 6.88 GBP

AGY.L Share Statistics

Avg. Volume (3 month) 0 GBP
Avg. Daily Volume (10-Days) 0 GBP
Shares Outstanding 679.11M
Float 95.45M
Short Ratio N/A
% Held by Insiders 123.30%
% Held by Institutions 6.23%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2022
Most Recent Quarter (mrq) June 30, 2022
Next Fiscal Year End June 30, 2023

Profitability

Profit Margin -18.93%
Operating Margin (ttm) -17.0030%
Gross Margin 68.03%
EBITDA Margin -11.27%

Management Effectiveness

Return on Assets (ttm) -9.56%
Return on Equity (ttm) -31.69%

Income Statement

Revenue (ttm) 72.77M GBP
Revenue Per Share (ttm) 0.11 GBP
Quarterly Revenue Growth (yoy) -20.59%
Gross Profit (ttm) 49.51M GBP
EBITDA -8207000 GBP
Net Income Avi to Common (ttm) -13776000 GBP
Diluted EPS (ttm) -0.02
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 20.52M GBP
Total Cash Per Share (mrq) 0.03 GBP
Total Debt (mrq) 10.53M GBP
Total Debt/Equity (mrq) 27.42 GBP
Current Ratio (mrq) 2.381
Book Value Per Share (mrq) 0.06

Cash Flow Statement

Operating Cash Flow (ttm) -14372000 GBP
Levered Free Cash Flow (ttm) -11695250 GBP

Profile of Allergy Therapeutics plc

Country United Kingdom
State N/A
City Worthing
Address Dominion Way
ZIP BN14 8SA
Phone 44 1903 844 700
Website https://www.allergytherapeutics.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 600

Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Acarovac Plus, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.

Q&A For Allergy Therapeutics plc Stock

What is a current AGY.L stock price?

Allergy Therapeutics plc AGY.L stock price today per share is 2.85 GBP.

How to purchase Allergy Therapeutics plc stock?

You can buy AGY.L shares on the LSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Allergy Therapeutics plc?

The stock symbol or ticker of Allergy Therapeutics plc is AGY.L.

Which industry does the Allergy Therapeutics plc company belong to?

The Allergy Therapeutics plc industry is Drug Manufacturers-Specialty & Generic.

How many shares does Allergy Therapeutics plc have in circulation?

The max supply of Allergy Therapeutics plc shares is 47.66M.

What is Allergy Therapeutics plc Price to Earnings Ratio (PE Ratio)?

Allergy Therapeutics plc PE Ratio is now.

What was Allergy Therapeutics plc earnings per share over the trailing 12 months (TTM)?

Allergy Therapeutics plc EPS is -0.06 GBP over the trailing 12 months.

Which sector does the Allergy Therapeutics plc company belong to?

The Allergy Therapeutics plc sector is Healthcare.

Allergy Therapeutics plc AGY.L included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
FTSE AIM All-Share Index FTAI 75.51 GBP 966.76 USD
-0.02
1.06M GBP 755.91 GBP 966.76 USD 763.17 GBP 976.05 USD 1.06M GBP